TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 6 | 3 | 4 | -4 | -24 | 0 | -3 |
| S | %wins | 0 | 0 | 0 | 100 | 100 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/21 17:05 | 9/1/21 | BIOBI | Bio-Rad Laboratories, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Last Andrew J. | CA | O | EVP,COO | S.d | -1,626 | 813.10 | 0 | -2 | -54 | 2 | D | ||||||||||||||
3/26/15 18:53 | 3/25/15 | AFFX | Affymetrix Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Last Andrew J. | CA | O | EVP,COO | S.d | -1,407 | 12.79 | 13 | -110 | -39 | 170 | D | 168 | 87 | 58 | 30 | 14 | 4 | 0 | -1 | 6 | 3 | 4 | -4 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |